Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Morton

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 2, 2022
A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancerJoelle Helou, Gerard Morton, Alex Kiss, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2018
MRI-based automated detection of implanted low dose rate (LDR) brachytherapy seeds using quantitative susceptibility mapping (QSM) and unsupervised machine learning (ML)Reyhaneh Nosrati, Abraam Soliman, Habib Safigholi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2018
Personal prostate-specific antigen screening and treatment choices for localized prostate cancer among expert physiciansChristopher Wallis, Douglas Cheung, Laurence Klotz, et al.
Radiation Oncology (London, England)|April 24, 2015
Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancerWilliam Chu, D Andrew Loblaw, Kelvin Chan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2005
Long-term outcome of postorchiectomy surveillance for Stage I testicular seminomaRichard Choo, Gillian Thomas, Tony Woo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?Richard Choo, George Hruby, Julie Hong, et al.
Advances in Radiation Oncology|January 19, 2026
Innovative and Customized 3-Dimensional-Printed Mold Brachytherapy Treatment of Genital Extramammary Paget's DiseaseRuben Del Castillo Pacora, Moti R Paudel, Mackenzie Smith, et al.
Brachytherapy|May 19, 2026
Core competencies in prostate HDR brachytherapy: An American Brachytherapy Society Endorsed Competency FrameworkAmandeep S Taggar, Joel Poder, Arun Goel, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2017
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate CancerW James Morris, Scott Tyldesley, Sree Rodda, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 18, 2022
Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancerKevin Martell, Hans Chung, Gerard Morton, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 2, 2022
A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancerJoelle Helou, Gerard Morton, Alex Kiss, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2018
MRI-based automated detection of implanted low dose rate (LDR) brachytherapy seeds using quantitative susceptibility mapping (QSM) and unsupervised machine learning (ML)Reyhaneh Nosrati, Abraam Soliman, Habib Safigholi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2018
Personal prostate-specific antigen screening and treatment choices for localized prostate cancer among expert physiciansChristopher Wallis, Douglas Cheung, Laurence Klotz, et al.
Radiation Oncology (London, England)|April 24, 2015
Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancerWilliam Chu, D Andrew Loblaw, Kelvin Chan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2005
Long-term outcome of postorchiectomy surveillance for Stage I testicular seminomaRichard Choo, Gillian Thomas, Tony Woo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?Richard Choo, George Hruby, Julie Hong, et al.
Advances in Radiation Oncology|January 19, 2026
Innovative and Customized 3-Dimensional-Printed Mold Brachytherapy Treatment of Genital Extramammary Paget's DiseaseRuben Del Castillo Pacora, Moti R Paudel, Mackenzie Smith, et al.
Brachytherapy|May 19, 2026
Core competencies in prostate HDR brachytherapy: An American Brachytherapy Society Endorsed Competency FrameworkAmandeep S Taggar, Joel Poder, Arun Goel, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2017
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate CancerW James Morris, Scott Tyldesley, Sree Rodda, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 18, 2022
Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancerKevin Martell, Hans Chung, Gerard Morton, et al.
Pageof 13